Nutrien Ltd. Q2 2026 Earnings Recap

Nutrien’s shares fell 3.7% after the earnings release, primarily driven by cautious nitrogen market outlook and deceleration in global urea prices during a seasonally weak demand period exacerbated by geopolitical uncertainty.

Key Takeaways

• Adjusted EBITDA reached $2.4 billion in Q2 and $3.5 billion in H1 2026, up 6% year-over-year.
• Potash volumes hit record levels, with controllable cash costs flat YoY and automation enabling cost discipline.
• Proprietary crop nutrients gross margin grew 10%, supported by targeted capacity expansions despite softer overall fertilizer demand.
• Nitrogen segment faced price softness in Q2 due to seasonal factors and geopolitical disruptions, though the North American assets remain cost advantaged.
• Continued portfolio optimization with $1 billion in gross proceeds generated from asset divestitures since late 2024; strategic reviews underway for phosphate and other segments.